Both in Pharmaceuticals
Bicara Therapeutics vs Aclaris Therapeutics
Over the past year BCAX returned −45.1% and ACRS returned +44.7%; their daily moves had a correlation of 0.19.
BCAX −45.1% ACRS +44.7%Growth of $1, one year, split-adjusted
| Metric | BCAX | ACRS |
|---|---|---|
| Price | $8.96 | $3.74 |
| Market cap | $592.9M | $579.6M |
| Today | +12.99% | −1.58% |
| 1 month | −48.2% | −12.4% |
| 6 months | −61.3% | −21.3% |
| Year to date | −46.8% | +24.3% |
| 1 year | −44.9% | +48.4% |
| Revenue growth (YoY) | — | −8.3% |
| Gross margin | — | 86.6% |
| Net margin | — | −1320.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 70.5× |
| Net cash | $497.3M | $91.6M |
| Dividend yield | — | — |
| Volatility (60d) | 134.8% | 75.8% |
| Short % of float | 23.9% | 12.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).